Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues, net of discounts $ 49,263 $ 40,616 $ 155,296 $ 105,688
Costs and expenses applicable to revenues (23,206) (15,513) (68,207) (46,243)
Gross profit 26,057 25,103 87,089 59,445
Operating expenses        
Selling, general and administrative expenses 22,581 24,173 67,263 74,521
Depreciation and amortization 8,133 7,237 23,266 20,416
Write-downs, recoveries and other charges, net 0 3 186 690
Impairment loss 127 4,100 1,823 203,464
Loss from operations (4,784) (10,410) (5,449) (239,646)
Interest income 138 96 371 276
Other income 350 461 844 756
Interest expense (5,959) (5,476) (17,516) (15,108)
Accretion expense (767) (4,354) (8,283) (12,471)
Provision for debt obligation fee (423) (423) (1,255) (13,342)
(Loss) gains from change in fair value of financial instruments (300) 244 10 5,170
Loss before income taxes (11,745) (19,862) (31,278) (274,365)
Income tax expense 4,090 5,609 19,265 12,272
Net loss $ (15,835) $ (25,471) $ (50,543) $ (286,637)
Net loss per share - basic and diluted $ (0.09) $ (0.15) $ (0.29) $ (1.67)
Weighted average number of common shares outstanding - basic and diluted 171,718 171,643 171,718 171,651